FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...